Moderna

Moderna, Inc. is a pharmaceutical and biotechnology company headquartered in Cambridge, Massachusetts. It specializes in RNA therapeutics, particularly mRNA vaccines, which use messenger RNA (mRNA) to prompt the body to produce an immune response. The company's name is a combination of "modified," "RNA," and "modern."

Its primary commercial product is the Moderna COVID-19 vaccine, known as Spikevax. Moderna has an extensive pipeline with 45 treatment and vaccine candidates, 38 of which have entered clinical trials. These include vaccines for diseases such as influenza, HIV, respiratory syncytial virus, and others.

Additionally, the company is developing treatments for conditions like acute decompensated heart failure and various forms of cancer using different therapeutic approaches, including cell therapy and immunotherapy. They are also working on regenerative medicine treatments for conditions like myocardial ischemia.

Outbound investment captured

Moderna to Build mRNA Vaccine Factory in Kenya

Moderna, a leading biotechnology company specializing in mRNA therapeutics and vaccines, has collaborated with the Government of Kenya to establish an mRNA manufacturing facility in the country, marking its first such facility in Africa. This partnership aims to provide Kenya and the African continent access to mRNA vaccines, enhancing health

Sailing SignalSS_editor